Obesitrol

Retirée du marché américain le 9 November 2023 (selon le DSLD)

Nutripharm, food supplement from the US market

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

• Conditions légales

  Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

• Official label: Obesitrol
  Entered into DSLD on 23 March 2018. Retirée du marché américain le 22 August 2019 (selon le DSLD).

  • Active ingredient added : Chromax (500 mcg)
  • Active ingredient added : Ginger (50 mg)
  • Active ingredient added : Glucomannan (1,000 mg)
  • Active ingredient added : Phenylethylamine (37.5 mg)
  • Active ingredient added : ThermoDiamine (10 mg)
  • Active ingredient added : Vitamin B12 (500 mcg)
  • Active ingredient removed : R-Alpha Lipoic Acid (150 mg)
  • Active ingredient removed : White Kidney Bean 10:1 extract (900 mg)
  • Same quantity, different name: Caffeine Anhydrous in this version; Cinnamon bark 10:1 extract on the displayed label (200 mg)
  • Same quantity, different name: Razberi-K in this version; Flax seed on the displayed label (100 mg)
  • Different quantity per serving : Chromium: 60 mcg in this version; 200 mcg on the displayed label

• Official label: Obesitrol
  Entered into DSLD on 26 August 2014. Retirée du marché américain le 17 October 2017 (selon le DSLD).

  • Active ingredient added : Caffeine Anhydrous (150 mg)
  • Active ingredient added : Cissus quadrangularis (150 mg)
  • Active ingredient added : Cumin (25 mg)
  • Active ingredient added : Irvingia gabonensis (150 mg)
  • Active ingredient added : Lady’s Mantle (60 mg)
  • Active ingredient added : Olive (50 mg)
  • Active ingredient added : Wild Mint (20 mg)
  • Active ingredient removed : Chromium (200 mcg)
  • Active ingredient removed : Cinnamon bark 10:1 extract (200 mg)
  • Active ingredient removed : Flax seed (100 mg)
  • Active ingredient removed : R-Alpha Lipoic Acid (150 mg)
  • Active ingredient removed : White Kidney Bean 10:1 extract (900 mg)

Source

Official label

List declared on 24 March 2020 (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging

Brand : Nutripharm